Do you want to read an article? Please log in or register.
Incidence, timing and risk factors of type 1 retinopathy of prematurity in a North American cohort
Blindness and Vision ImpairmentRetinal Diseases
Related content
Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology
Ophthalmology.
VanderVeen DK, Melia M, Yang MB, Hutchinson AK, Wilson LB, Lambert SR
doi: 10.1016/
RECOMMENDED
Retinal Diseases
Aggressive Posterior Retinopathy of Prematurity: Clinical and Quantitative Imaging Features in a Large North American Cohort
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
Ophthalmology.
Bellsmith KN, Brown J, Kim SJ, Goldstein IH, Coyner A, Ostmo S, Gupta K, Chan RVP, Kalpathy-Cramer J, Chiang MF, Campbell JP
doi: 10.1016/j.ophtha.2020.01.052.
RECOMMENDED
Retinal Diseases
Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study
JAMA Ophthalmol.
Quinn GE, Ying GS, Bell EF, Donohue PK, Morrison D, Tomlinson LA, Binenbaum G; G-ROP Study Group
doi: 10.1001/jamaophthalmol.
Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study
JAMA Ophthalmol.
Binenbaum G, Bell EF, Donohue P, Quinn G, Shaffer J, Tomlinson LA, Ying GS; G-ROP Study Group
doi: 10.1001/jamaophthalmol.
RECOMMENDED
Glaucoma and Ocular Pressure
Twelve-year incidence and baseline risk factors for pseudoexfoliation: The Thessaloniki Eye Study (An American Ophthalmological Society Thesis)
Am J Ophthalmol.
Topouzis F, Founti P, Yu F, Wilson MR, Coleman AL
doi: 10.1016/j.ajo.2019.05.005.
LensesCataracts
Five-year cumulative incidence and risk factors of Nd:YAG capsulotomy in 10044 hydrophobic acrylic 1-piece and 3-piece IOLs
Am J Ophthalmol.
Lindholm JM, Laine I, Tuuminen R
doi: 10.1016/j.ajo.
Retinal Diseases
Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria
JAMA Ophthalmol.
Binenbaum G, Tomlinson LA, de Alba Campomanes AG, Bell EF, Donohue P, Morrison D, Quinn GE, Repka MX, Rogers D, Yang MB, Yu Y, Ying GS, Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group.
doi: 10.1001/jamaophthalmol.
UveitisFurther Publications
Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors
Am J Ophthalmol
Roldan AM, Zebardast N, Pistilli M, Khachatryan N, Payal A, Begum H, Artornsombudh P, Pujari SS, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Buchanich JM, Kempen JH, Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group.
doi: 10.1016/j.ajo.2021.10.031
Retinal Diseases
Type 2 Diabetes Genetic Variants and Risk of Diabetic Retinopathy.
Ophthalmology.
Chong YH, Fan Q, Tham YC, Gan A, Tan SP, Tan G, Wang JJ, Mitchell P, Wong TY, Cheng CY
doi: 10.1016/j.ophtha.2016.11.016.